Evidence map›Paper›PMID 39659563›Full record

ArticleHuman reproduction open2023

Etiology, histology, and long-term outcome of bilateral testicular regression: a large Belgian series.

L J W Tack, C Brachet, V Beauloye, C Heinrichs, E Boros, K De Waele, S van der Straaten, S Van Aken, M Craen, A Lemay and 13 more

Abstract read
In one paragraph

Article in Human reproduction open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

L J W TackDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.ORCID https://orcid.org/0000-0001-9352-5444
C BrachetUniversité libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Paediatric Endocrinology Unit, Brussels, Belgium.
V BeauloyeDepartment of Pediatric Endocrinology, Université Catholique de Louvain-UCLouvain, Brussels, Belgium.
C HeinrichsUniversité libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Paediatric Endocrinology Unit, Brussels, Belgium.
E BorosUniversité libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Paediatric Endocrinology Unit, Brussels, Belgium.ORCID https://orcid.org/0000-0001-6456-5228
K De WaeleDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.
S van der StraatenDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.ORCID https://orcid.org/0000-0003-0472-2046
S Van AkenDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.
M CraenDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.
A LemayDepartment of Pediatrics, AZ Turnhout, Turnhout, Belgium.
A RochtusDepartment of Pediatric Endocrinology, University Hospitals Leuven, Leuven, Belgium.
K CasteelsDepartment of Pediatric Endocrinology, University Hospitals Leuven, Leuven, Belgium.
D BeckersDepartment of Pediatric Endocrinology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
T MourauxDepartment of Pediatric Endocrinology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
K LoggheDepartment of Pediatric Endocrinology, AZ Delta, Roeselare, Belgium.
M Van LoockeDepartment of Pediatric Endocrinology, AZ Delta, Roeselare, Belgium.
G MassaDepartment of Pediatric Endocrinology, Jessa Ziekenhuis, Hasselt, Belgium.
K Van de VijverDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
H SyrynCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
J Van De VeldeDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.
E De BaereCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
H VerdinCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
M CoolsDepartment of Internal Medicine and Pediatrics, Ghent University, Pediatric Endocrinology Service, Ghent University Hospital, Belgium, Ghent.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

study questionWhat is the long-term outcome of individuals born with bilateral testicular regression (BTR) in relation to its underlying etiology? SUMMARY ANSWER: Statural growth and pubertal development are adequate with incremental doses of testosterone replacement therapy (TRT); however, penile growth is often suboptimal, especially in those with a suspected genetic etiology (i.e. heterozygous WHAT IS KNOWN ALREADY: BTR is a rare and poorly understood condition. Although a vascular origin has been postulated, heterozygous missense variants in STUDY DESIGN SIZE DURATION: For this cross-sectional study, individuals with BTR were recruited in eight Belgian pediatric endocrinology departments, between December 2019 and December 2022. A physical exam was performed cross-sectionally in all 17 end-pubertal participants and a quality of care questionnaire was completed by 11 of them. Exome-based panel testing of 241 genes involved in gonadal development and spermatogenesis was performed along with a retrospective analysis of presentation and management. A centralized histological review of gonadal rests was done for 10 participants. PARTICIPANTS/MATERIALS SETTING

methodsA total of 35 participants (33 with male, 1 with female, and 1 with non-binary gender identity) were recruited at a mean age of 15.0 ± 5.7 years. MAIN RESULTS AND THE ROLE OF CHANCE: The median age at presentation was 1.2 years [0-14 years]. Maternal gestational complications were common (38.2%), with a notably high incidence of monozygotic twin pregnancies (8.8%). Heterozygous (likely) pathogenic missense variants in LIMITATIONS REASONS FOR CAUTION: The limitations of this study include the relatively small sample size (n = 35) and the few individuals with WIDER IMPLICATIONS OF THE

findingsTRT provides adequate statural growth, even when initiated in late adolescence, thus providing time for physicians to explore the patients' gender identity if needed. However, sufficient and understandable information regarding the effects and side effects of TRT is required throughout the management of these patients. SPL remains suboptimal in many individuals and could be improved by TRT during infancy to mimic the physiological mini-puberty. An environmental origin in some participants is supported by the high incidence of gestational complications (38.2%) and by the three monozygotic twin pregnancies discordant for the BTR phenotype. Individuals with a heterozygous STUDY FUNDING/COMPETING INTERESTS: Funding was provided by the Belgian Society for Pediatric Endocrinology and Diabetology (BESPEED) and by Ghent University Hospital under the NucleUZ Grant (E.D.B.). M.C. and E.D.B. are supported by an FWO senior clinical investigator grant (1801018N and 1802220N, respectively). The authors report no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

Indexed as

DHX37differences of sex development (DSD)hormone replacement therapylong-term outcometesticular regressionvanished testes

Identifiers

PMID39659563
PMCPMC11631441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.